LOS ANGELES - s4story -- Jacob Batalon's career skyrocketed after being discovered at iPOP!, the twice annual talent showcase event, and he has become best known for his role as "Ned" in the latest "Spiderman" series movies. His first big role was in 2017 in "Spider-Man: Homecoming." Since then, he's appeared in almost 20 films with the most recent release this year, "Novocaine." He's also appeared in the TV series "Reginald the Vampire" from 2022 – 2024. His role continues as he films "Spider-Man: Brand New Day", which just wrapped filming in Scotland, and now moves to London. The live action feature, which is directed by directed by Destin Daniel Cretton (https://pro.imdb.com/name/nm2308774/), stars Tom Holland (https://pro.imdb.com/name/nm4043618/), Zendaya (https://pro.imdb.com/name/nm3918035/), Jacob Batalon (https://pro.imdb.com/name/nm8188622/), Sadie Sink (https://pro.imdb.com/name/nm5584750/), Liza Colón-Zayas, Jon Bernthal (https://pro.imdb.com/name/nm1256532/), and Michael Mando (https://pro.imdb.com/name/nm3103126/), . It will be released  July 2026 in theaters.

More on S For Story

• University Rankings Index Announces 2025 Rankings of the Top US Online Universities
• Boston Industrial Solutions Launches Citrine® CAL-685 Silicone Primer
• Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection
• New Report from The Kryder Law Group Reveals Alarming Construction Fatalities and Demographic Disparities Over the Past Decade
• EMBER™, the Only Standardized System Linking Workforce Identity to Growth, Appoints Global Brand Visionary Bret Sanford-Chung to Board of Directors

###

About iPOP!

iPop promotes emerging talent to leading agents, managers, casting directors, and music industry professionals. In business over 20 years, iPOP! is held in Los Angeles every winter and summer. Performers attend from over 30 different countries. At the event, they work with industry experts and participate in competitions in front of the many agents and managers who are looking for the stars of tomorrow.